Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05221918 · ClinicalTrials.gov registry record
A Study to Compare CSF Flow Metrics Across Platforms
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 10
- Enrollment target
NCT05221918: Completed study, sponsored by Mayo Clinic.
NCT05221918 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05221918 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this research is to find out more about detecting movement of CSF (fluid around the brain) with MRI. Researchers are doing this research study to find out how measurements of CSF movement differ among MRI machines and how image quality is changed by reducing the scan time.
Primary Outcome
Flow metrics such as average total flow will be compared among multiple MRI scanners
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-09-14 |
| Est. Completion | 2023-02-20 |
What the finished NCT05221918 record still lists
NCT05221918 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05221918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05221918 about?
NCT05221918 is a clinical study titled "A Study to Compare CSF Flow Metrics Across Platforms". The purpose of this research is to find out more about detecting movement of CSF (fluid around the brain) with MRI. Researchers are doing this research study to find out how measurements of CSF movement differ among MRI machines and how image quality is changed by reducing the scan time.
What is the current status of trial NCT05221918?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2022-09-14. Estimated completion is 2023-02-20.
Who is sponsoring clinical trial NCT05221918?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI